Premium
Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus
Author(s) -
d'Emden Michael C,
Shaw Jonathan E,
Jones Graham R,
Cheung N Wah
Publication year - 2015
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja15.00041
Subject(s) - glycated haemoglobin , diabetes mellitus , medicine , intensive care medicine , glycated hemoglobin , diagnostic test , type 2 diabetes mellitus , test (biology) , pediatrics , type 2 diabetes , endocrinology , paleontology , biology
Summary Glycated haemoglobin (HbA 1c ) assessment for the diagnosis of diabetes mellitus overcomes many practical problems associated with traditional blood glucose measurements. However, the test is not without limitations of which the medical practitioner needs to be aware. The possibility of an individual having a medical condition that interferes with the test should always be considered, even though these conditions are rare in most Australian communities. Appropriately used, HbA 1c assessment should provide a cost‐effective, efficient and simple tool for the early diagnosis of type 2 diabetes.